Drug Discovery World

OCTOBER 16, 2023

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. Here, DDW’s Megan Thomas highlights the research taking place and where this is happening. The university aims to identify treatments for life-threatening anti-microbial diseases and metabolic disorders.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

XTalks

JANUARY 17, 2024

Oncology is recognized as having the largest drug pipeline of any therapeutic area. Estimates based on publicly available information suggest more than 40 percent of all new therapies in development are cancer treatments. It’s very positive and it’s going to help move forward the pathway for new drugs.”

Clinical Trials 124

Clinical Trials Clinical Trials Trials Gene Therapy 124

The Pharma Data

NOVEMBER 10, 2020

Weiner, chairman of the scientific advisory board of Tiziana Life Sciences, commented: “We understand that this will be the first-ever study with ‘take-home’ capsules of any mAb for immunotherapies for human diseases. Grand View Research August 2018 ( [link] ). NEW YORK and LONDON, Nov. and Europe. Dr. Howard L.

Life Science 40

Life Science Clinical Trials Clinical Trials Trials 40

XTalks

JANUARY 23, 2024

Rare diseases, often overlooked in the broader medical research field, affect a small percentage of the population yet carry a significant burden for those diagnosed and their families. Among these, rare pediatric diseases present unique challenges and opportunities for rare disease drug development.

Development 72

Development Hormones Drugs Trials 72

The Pharma Data

SEPTEMBER 29, 2021

The new FIND-CKD study extends our clinical research for finerenone to a non-diabetic population where the unmet need is high for brand spanking new treatments to delay disease progression.”. About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.

Clinical Development 52

Clinical Development Development Clinical Trials Clinical Trials 52

pharmaphorum

DECEMBER 1, 2022

To ease this burden, the life sciences industry has been searching for ways to make clinical trials more accessible for patients and to drive participation numbers, increase participant diversity, and improve overall patient experience. Imagine, clinical research as an accessible care option to anyone.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Clinical Research 104

XTalks

MAY 23, 2024

With over 25 years of experience, Dr. Duke’s expertise in growth and bone disorders has been instrumental in advancing clinical research and improving patient outcomes. Navigating the Regulatory Landscape The regulatory environment plays a significant role in shaping drug development strategies for rare diseases.

Clinical Trials 52

Clinical Trials Clinical Trials Hormones Trials 52

pharmaphorum

MAY 27, 2021

Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted. This is definitely a time for the life sciences industry to be proud of our accomplishments. Implementing AI/machine learning models.

Clinical Trials 117

Clinical Trials Clinical Trials Trials Life Science 117

XTalks

APRIL 11, 2024

The Cumulus Neuroassessment Platform is designed to collect EEG data via a US Food and Drug Administration (FDA) 510(k) cleared and UK Conformity Assessment (UKCA)-marked dry sensor EEG headset. EEG Biomarkers in Clinical Development Historically, technical constraints have hindered the widespread adoption of EEG in research settings.

Clinical Trials 110

Clinical Trials Clinical Trials Development Clinical Development 110

XTalks

MAY 19, 2023

It is clear that the clinical research landscape continues to expand at a substantial rate. percent of all trials), underscoring the importance of both interventional and observational research in understanding health and disease​. Rising Cost of Drug Development Developing a new drug is an expensive venture.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

XTalks

JANUARY 17, 2024

Lupus, a complex autoimmune disease, has brought a substantial challenge to researchers and healthcare professionals. Understanding this condition and its various manifestations, as well as developing effective treatments, has been the focus of ongoing investigation in lupus clinical research for many years.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

XTalks

NOVEMBER 1, 2023

The revolution in clinical research is here, and it’s embodied by a single, powerful word: “patients.” The inclusion of patients during clinical development is not only a moral imperative but a strategic necessity in modern medical research.

Clinical Trials 87

Clinical Trials Clinical Trials Trials Clinical Development 87

pharmaphorum

OCTOBER 7, 2021

Dr Jean-Meidi Alili is a senior pharmacist in charge of Medicines and Research at the French healthcare network for rare metabolic diseases (G2M), where he is notably involved in implementing a drugs observatory and two ‘one-stop-shops’ in research and pharmacy.

Genome 96

Genome Genomics Medicine Life Science 96

XTalks

MAY 9, 2024

As we explore Genmab’s strategic vision, technological advancements and the next frontier in antibody research, we gain insights into the future of medicine — a future where Genmab’s cutting-edge therapies are poised to transform patient care and meet the complex challenges of the next generation of healthcare.

Antibody 52

Antibody Clinical Trials Clinical Trials Medicine 52

pharmaphorum

FEBRUARY 11, 2021

The online event also heard from Pfizer and patient advocate representatives and looked at how the NIHR’s collective approach allows life sciences firms to engage with patients while remaining aligned with ethics guidelines and codes of conduct – providing a UK solution to a global problem.

Clinical Trials 89

Clinical Trials Clinical Trials Trials Clinical Research 89

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Clinical Data Pipeline for Data Review and Analyses.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

pharmaphorum

APRIL 7, 2021

Genmab’s success has been founded on Darzalex (daratumumab), the blockbuster multiple myeloma drug that it developed in partnership with Johnson & Johnson’s Janssen unit. With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies.

Antibody 65

Antibody Life Science Development Regulation 65

The Pharma Data

SEPTEMBER 11, 2020

Starpharma experimenting with Gilead’s antiviral drug for easier administration. Melbourne-based Starpharma has announced it has applied its novel DEP drug delivery technology to create a long ? Covid-19 command center aims to accelerate clinical research by individual sponsors to combat disease.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

XTalks

MARCH 5, 2021

With locations in 40 countries worldwide, ICON offers a full range of consulting, clinical development and commercialization services. PRA Health Sciences has been focused on integrated drug development solutions in early preclinical and clinical phases, as well as biometrics, embedded and real-world solutions.

Development 98

Development Trials Clinical Development Medicine 98

pharmaphorum

SEPTEMBER 12, 2022

“Across LabCorp , we innovate through science and technology, with access to approximately 2,500 [doctors] and PhDs and over 700 patients. This reach allows us to support 82% of the novel drugs and therapeutic products approved by the US FDA, including 63% of those specific to oncology,” Reddy states. Tailored oncology.

Genome 101

Genome Genomics Clinical Trials Clinical Trials 101

Drug Discovery World

OCTOBER 7, 2022

Earlier this year, Cancer Research UK (CRUK) launched its innovation engine, Cancer Research Horizons, to streamline drug discovery through the combination of its commercial and therapeutics teams. It’s about working together with our partners in the life science sector to get world class innovations to patients. .

HR 52

HR Research Drugs Development 52

XTalks

SEPTEMBER 5, 2023

Xtalks spoke with Maria Reyes Boceta-Muñoz, Clinical Operations Head of Development R&D at GlaxoSmithKline in Spain, Portugal & Israel, to understand the current vaccine development climate and where the sector is headed.

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

XTalks

MAY 20, 2021

Today is Clinical Trials Day 2021 — a day for recognizing the importance of clinical research in protecting and improving global health. As the efforts to develop a vaccine against SARS-CoV-2 intensified, clinical research groups found themselves designing trials to evaluate them under the confines of tighter timelines.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Vaccination 105

The Pharma Data

NOVEMBER 1, 2020

Highly innovative first-in-class study for treating COVID-19 disease with nasally administered drug. Clinical Data Expected by End of Year. Tiziana Life Sciences plc. (“Tiziana” or the “Company”). . (“Tiziana” or the “Company”).

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Life Science 52

XTalks

APRIL 24, 2023

According to Dr. Melanie Blank, clinical team leader for General Medicine Branch 1 at the US Food and Drug Administration’s (FDA) Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), the agency is seeing one or two new applications coming in every week for new gene therapies for different diseases.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

XTalks

MARCH 13, 2023

The US Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies (OTAT) held a recent town hall where three experts from the regulator provided guidance on how to design and conduct gene therapy clinical trials for rare diseases.

Gene Therapy 52

Gene Therapy Clinical Trials Clinical Trials Gene 52

pharmaphorum

MAY 25, 2021

Opportunities are growing for real-world evidence research as the technology matures and a pioneering new partnership between Savana, utilising its AI-driven clinical research methodology, and BREATHE aims to drive innovative research using this new way of working. The benefits of RWE.

Big Data 126

Big Data Clinical Research Research Trials 126

pharmaphorum

JANUARY 27, 2023

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds. We talk a lot in clinical trials and drug development about benefit,” Dr Mullen said. But who is benefitting?

Clinical Trials 96

Clinical Trials Clinical Trials Trials Development 96

The Pharma Data

NOVEMBER 19, 2020

Previously, Baffa was Therapeutic Area Head of Oncology, Global Clinical Development for Shire. Hojvat served as the director of the Division of Microbiology Devices at the Center for Devices and Radiological Health at the Food and Drug Administration for 12 years. Source link.

Life Science 52

Life Science Research Development Radiology 52

The Pharma Data

DECEMBER 17, 2020

Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences.

Development 52

Development Gene Therapy Engineer Life Science 52

The Pharma Data

JANUARY 3, 2021

We are very honored to have someone of Dr. Zeldis’ caliber lead our scientific research and clinical development teams. At NexImmune, he will oversee all aspects of research and development. . GAITHERSBURG, Md.,

Immune Response 40

Immune Response Clinical Trials Clinical Trials Development 40

The Pharma Data

NOVEMBER 5, 2020

Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. Prior to that, Taveras was vice president of Small Molecule Drug Discovery and CMC Development at Biogen Idec, and Alantos Pharmaceuticals, which was acquired by Amgen in 2007.

Genome 40

Genome Genomics Medicine Life Science 40

XTalks

MAY 11, 2023

The goal is to make sure critical data doesn’t get caught up in MTAs [material transfer agreements] at academic institutions, or industry ownership issues, but truly makes these very important data available for everyone to use for meaningful research. So few rare diseases actually have meaningful therapies.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

XTalks

NOVEMBER 19, 2021

While the aim in many cases is to use biomarkers to assess a patient’s quantitative response to a study drug, it is important to ascertain a link between the drug’s mechanism of action and an ensuing biological effect in order for it to be a reliable readout of drug response. The Double-Edged Sword of Cardiac Biomarkers.

Clinical Trials 98

Clinical Trials Clinical Trials Trials In-Vitro 98

XTalks

SEPTEMBER 14, 2020

Drugs and Vaccines. The most promising news about any drug thus far in the pandemic just came out of the UK where Southampton researchers together with Synairgen showed that an inhaled form of interferon-? helped protect COVID-19 patients against developing severe disease. Drugs, Vaccines and Masks.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92

XTalks

DECEMBER 4, 2020

Since CKD is a broad diagnosis that can have a variety of underlying causes, a beneficial focus of current research strategies has been to identify biomarkers and develop diagnostics that can help stratify patients into clinically relevant categories and help guide their management.

Trials 52

Trials Clinical Trials Clinical Trials Antibody 52